Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism – The SWAN Study

BACKGROUND: Warfarin is an anticoagulant medication proven effective in the initial treatment and secondary prevention of venous thromboembolism. Anti-Xa direct oral anticoagulants are alternatives to warfarin; however there is limited data assessing satisfaction after switching from warfarin to an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendriks, Thomas, McGregor, Scott, Rakesh, Shilpa, Robinson, Julie, Ho, Kwok M., Baker, Ross
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272044/
https://www.ncbi.nlm.nih.gov/pubmed/32497116
http://dx.doi.org/10.1371/journal.pone.0234048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272044/
https://www.ncbi.nlm.nih.gov/pubmed/32497116
http://dx.doi.org/10.1371/journal.pone.0234048

Ejemplares similares